Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reducedejection fraction and type 2 diabetes

被引：0
|
作者：
El-Chouli, M. [1 ]
Barcella, C. A. [1 ]
Mohr, G. H. [2 ]
Mudalige, N. [3 ]
Folke, F. [4 ]
Torp-Pedersen, C. [5 ]
Bruun, N. E. [1 ]
Lindhardsen, J. [4 ]
Ahlehoff, O. [6 ]
Gislason, G. [4 ]
Skov, L. [4 ]
Eroglu, T. [4 ]
机构：
[1] Zealand Univ Hosp, Copenhagen, Denmark
[2] Glostrup Cty Hosp, Glostrup, Denmark
[3] Univ British Columbia, Hlth Syst Intelligence Unit, Data Analyt, Vancouver, BC, Canada
[4] Herlev & Gentofte Hosp, Copenhagen, Denmark
[5] Nordsjaellands Hosp, Hillerod, Denmark
[6] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Epicardial adipose tissue and heart failure in patients with a high cardiovascular risk
    Seo, J. W.
    Lee, C. J.
    Oh, J. W.
    Lee, S. H.
    Kang, S. M.
    Park, S. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 106 - 106
  • [42] Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
    Johansson, Lars
    Hockings, Paul D.
    Johnsson, Eva
    Dronamraju, Nalina
    Maaske, Jill
    Garcia-Sanchez, Ricardo
    Wilding, John P. H.
    DIABETES OBESITY & METABOLISM, 2020, 22 (07): : 1094 - 1101
  • [43] Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
    Johanssoni, I.
    Hockings, P.
    Johnsson, E. K.
    Maaskes, J.
    Garcia-Sanchez, R.
    Wilding, J. P.
    DIABETOLOGIA, 2018, 61 : S314 - S314
  • [44] Dapagliflozin plus Saxagliptin Add-On to Metformin Reduces Liver Fat and Adipose Tissue Volume in Patients with Type 2 Diabetes
    Wilding, John P.
    Hockings, Paul
    Johnsson, Eva K.
    Maaske, Jill
    Garcia-Sanchez, Ricardo
    Johansson, Lars
    DIABETES, 2018, 67
  • [45] Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus
    Song, Xiang-ting
    Wei, Yu-long
    Rui, Yi-fei
    Fan, Li
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (07)
  • [46] Effects of epicardial adipose tissue on cardiac function and exercise hemodynamics in patients with Heart Failure with Preserved Ejection Fraction
    Gomes, Diana De Oliveira
    Brazile, Tiffany
    MacNamara, James
    Zamani, Sauyeh
    Hearon, Christopher
    Wakeham, Denis
    Nelson, Michael
    Levine, Benjamin
    Sarma, Satyam
    CIRCULATION, 2024, 150
  • [47] Dapagliflozin versus Empagliflozin for Improving Outcomes of Type 2 Diabetes Mellitus Patients with Heart Failure and Reduced Ejection Fraction
    Azuri, Joseph
    Aboalhasan, Enis
    Hammerman, Ariel
    Arbel, Ronen
    CIRCULATION, 2021, 144
  • [48] Epicardial adipose tissue is associated with an increased risk of mortality and hospitalizations in patients with heart failure with preserved ejection fraction
    Grubler, M.
    Binder, C.
    Duca, F.
    Kronberger, C.
    Polednicek, M.
    Rettl, R.
    Hartmann, A.
    Beitzke, D.
    Loewe, C.
    Dona, C.
    Badr-Eslam, R.
    Hengstenberg, C.
    Kastner, J.
    Bergler-Klein, J.
    Kammerlander, A. A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [49] Genome-wide screening for circRNAs in epicardial adipose tissue of heart failure patients with preserved ejection fraction
    He, Shan
    Zhu, Huagang
    Zhang, Jianjun
    Yang, Xinchun
    Zhao, Lei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (07): : 4610 - +
  • [50] Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction
    Nassiba Menghoum
    Maria Chiara Badii
    Martin Leroy
    Marie Parra
    Clotilde Roy
    Sibille Lejeune
    David Vancraeynest
    Agnes Pasquet
    Dulce Brito
    Barbara Casadei
    Christophe Depoix
    Gerasimos Filippatos
    Damien Gruson
    Frank Edelmann
    Vanessa M. Ferreira
    Renaud Lhommel
    Masliza Mahmod
    Stefan Neubauer
    Alexandre Persu
    Stefan Piechnik
    Kristian Hellenkamp
    Ignatios Ikonomidis
    Bartosz Krakowiak
    Burkert Pieske
    Elisabeth Pieske-Kraigher
    Fausto Pinto
    Piotr Ponikowski
    Michele Senni
    Jean-Noël Trochu
    Nancy Van Overstraeten
    Rolf Wachter
    Bernhard L. Gerber
    Jean-Luc Balligand
    Christophe Beauloye
    Anne-Catherine Pouleur
    Cardiovascular Diabetology, 24 (1)
12345